Mereo BioPharma Group (MREO)

AI Score

Unlock

2.35

0.18 (8.29%)

At close: Apr 02, 2025, 3:59 PM

2.25

-4.05%

After-hours: Apr 02, 2025, 07:40 PM EDT

Mereo BioPharma Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	10M	1.51M	36.46M	393K	-122K	n/a	-3.29M	n/a
Cost of Revenue	n/a	2.57M	936K	17.91M	16.35M	23.61M	22.7M	34.61M	24.56M
Gross Profit	n/a	7.43M	571K	18.56M	-15.95M	-23.73M	-22.7M	-37.89M	-24.56M
Operating Income	-47.36M	-28.42M	-43.57M	-20.94M	-37.57M	-39.52M	-35.21M	-45.3M	-36.18M
Interest Income	3.04M	2.13M	696K	1K	44K	377K	306.83K	826.86K	195.14K
Pretax Income	-43.25M	-30M	-36.09M	14.24M	-166.45M	-41.12M	-37.31M	-46.95M	-33.72M
Net Income	-43.25M	-29.47M	-34.2M	12.72M	-163.63M	-34.84M	-32.03M	-38.8M	-28.39M
Selling & General & Admin	26.43M	18.42M	19.54M	15.93M	21.22M	15.91M	12.5M	10.7M	11.62M
Research & Development	20.93M	17.42M	24.96M	23.56M	-16.35M	-23.61M	22.7M	34.61M	24.56M
Other Expenses	n/a	n/a	811K	n/a	n/a	n/a	n/a	-293.33K	n/a
Operating Expenses	47.36M	35.84M	44.51M	39.49M	21.22M	15.91M	12.5M	10.7M	11.62M
Interest Expense	-1.37M	2.88M	3.36M	4M	6.38M	3.5M	2.36M	1.09M	179.76K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	38.42M	43.57M	57.4M	37.57M	39.52M	35.21M	45.3M	36.18M
Income Tax	n/a	-532K	-1.9M	1.52M	-2.82M	-6.27M	-5.28M	-8.15M	-5.33M
Shares Outstanding (Basic)	739.62M	659.45M	603.2M	583.67M	338.95M	89.34M	71.14M	69.01M	44.79M
Shares Outstanding (Diluted)	739.62M	659.45M	603.2M	583.67M	338.95M	89.42M	71.14M	69.01M	44.79M
EPS (Basic)	-0.06	-220.04	-350.07	149.93	-3.3K	-2.58K	-2.87K	-3.8K	-3.91K
EPS (Diluted)	-0.06	-220.04	-350.07	149.93	-3.3K	-2.58K	-2.87K	-3.8K	-3.91K
EBITDA	-47.36M	-26.06M	-42.06M	-5M	-37.52M	-37.56M	-34.86M	-44.44M	-38.41M
EBIT	-44.62M	-27.12M	-32.73M	24.62M	-159.67M	-37.62M	-32.89M	-45.6M	-33.74M
Depreciation & Amortization	n/a	1.06M	1.51M	866.47K	44K	1.95M	37.8K	36.08K	32.94K